CLEARWATER, Fla., May 24 /PRNewswire-FirstCall/ -- CRYO-CELL International, Inc. (OTC Bulletin Board: CCEL) (the Company) and CRYO-CELL de Mexico jointly announced today that CRYO-CELL de Mexico, the Company's licensed affiliate, has recently provided cord blood hematopoietic stem cells for use in a successful transplant procedure. The stem cells were used in the treatment of blackfan diamond anemia, a severe type of genetic anemia. The transplant was performed on a seven-year-old from El Salvador utilizing cord blood stem cells and marrow from a younger sibling. The child's parents had collected and banked the sibling's cord blood at birth; the initial processing and storage of the cells was performed at CRYO-CELL de Mexico in Guadalajara. The transplant procedure was performed on March 3, 2004 by Michael Trigg, MD, Chief, Division of Blood & Bone Marrow Transplantation at the Alfred I. duPont Hospital for Children in Wilmington, DE. The patient continues to be seen in clinic, and is progressing nicely. Dr. Trigg is a world-renowned pediatric transplant surgeon who treats many international patients. Dr. Trigg also chairs CRYO-CELL's Medical & Scientific Advisory Board. Cord blood stem cells have become increasingly used in clinical therapy for the treatment of leukemia, lymphoma, severe anemias and other diseases over the past five years. The first use of cord blood for treatment of anemia was in 1988; the use of cord blood for the treatment of hematological malignancies was pioneered in the early nineties. Elias Bemaras, CEO of CRYO-CELL de Mexico, and Mercedes Walton, CRYO-CELL Chairman and interim CEO, agree: "We have a strong sense of fulfillment of our corporate mission each time that stem cells banked with CRYO-CELL International by our clients are used for successful medical treatments. Based upon the information we have received, we are very encouraged with both the excellent progress of the recipient and the prognosis." The Company believes that, as it announces further applications and clinical uses of CRYO-CELL processed and preserved stem cells, this information can be used to assist both expectant parents and the medical community in determining the merits of preserving stem cells and their life-saving applications. About Alfred I. duPont Hospital for Children: The Alfred I. duPont Hospital for Children is a division of Nemours, headquartered in Jacksonville, Florida. Nemours provides institutions and services to restore and improve the health of children through patient centered care, teaching, research and health prevention. Nemours is one of the nation's largest pediatric subspecialty group practices with operations in Delaware, Florida, Maryland, New Jersey and Pennsylvania. About Michael Trigg, MD: Michael Trigg, MD, is Chief of the Blood & Bone Marrow Transplantation Division at Nemours' Alfred I. duPont Hospital for Children in Wilmington, DE, and is also a Professor of Pediatrics at Jefferson Medical School in Philadelphia, PA. Internationally renowned for pediatric marrow transplantation, Dr. Trigg is distinguished for his ability to treat high-risk patients. Dr. Trigg also chairs the Acute Lymphoblastic Leukemia (ALL) Open Trials Committee, a sub-group of the ALL Strategy Group, for the Children's Oncology Group, the largest worldwide cooperative group for the treatment of children with cancer and leukemia. Dr. Trigg is also the Principal Investigator for more than 20 ongoing research studies at Nemours. About CRYO-CELL de Mexico: Based in Guadalajara, Mexico and operating since 2000, CRYO-CELL de Mexico is the largest cord blood bank in the country with more than 10,500 specimens stored. It is the first facility of its kind in Latin America and operates in all Mexican states, Ecuador, Panama and Honduras. The operation and laboratory meets CRYO-CELL International's quality standards, which are verified by quality assurance audits. 01-800-999-CRYO; www.cryo-cell.com.mx About CRYO-CELL International, Inc.: Based in Clearwater, Florida, CRYO-CELL is the world's largest U-Cord(TM) stem cell banking firm, offering high-quality cord blood preservation exclusively for the benefit of newborn babies and possibly other members of their family. CRYO-CELL is accredited by the American Association of Blood Banks (AABB). CRYO-CELL is a publicly traded company. OTC Bulletin Board Symbol ... CCEL. Expectant parents or healthcare professionals may call 1-800-STOR-CELL (1-800-786-7235) or visit www.CRYO-CELL.com. Forward-Looking Statement Statements wherein the terms "believes", "intends", "projects" or "expects" as used are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs, many of which are outside the control of the Company. These uncertainties and other factors include any adverse effect or limitations caused by any governmental regulations, proceedings or actions, foreign and domestic; any continued or increased losses, or any inability to obtain acceptable financing, where desirable in the future, in connection with our operating or growth plans; any increased competition in our business; any decrease or slowdown in the number of people seeking to store umbilical cord blood stem cells or decrease in the number of people paying annual storage fees; the effect of any future reduced cash position and future inability to access borrowings; any adverse impacts on our revenue or operating margins due to the costs associated with increased growth in our business; any adverse developments impacting our continued relationship with and success of our licensees, foreign affiliates or investments in, or relationships with, foreign companies; any inability to achieve increases in revenue or earnings from umbilical cord blood stem cell storage; any future inability to substantially achieve the objectives expected from the successful implementation of our strategy; any decline in public market interest in the Company's business sector; any added requirements imposed on us by new laws or SEC regulations and costs thereof; any technological breakthrough or medical breakthrough that would render the Company's business of stem cell preservation obsolete; any material failure or malfunction in our storage facilities; any natural disaster such as a tornado, other disaster (fire) or act of terrorism that adversely affects stored specimens; the potential impact of negative market influences on the Company's portfolio of cash, cash equivalents and marketable securities; the costs associated with defending or prosecuting litigation matters and any material adverse result from such matters; decreases in asset valuations; any continued negative effect from adverse publicity in the past year regarding the Company's business operations; any new technology rendering the Company's patented equipment or business obsolete; any performance failures related to the Company's equipment or operations; any negative consequences resulting from deriving, shipping and storing specimens at a second location; any negative effect from the filed class action shareholder lawsuits; and other risks and uncertainties. The foregoing list is not exhaustive, and the Company disclaims any obligations to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements. Readers should carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-KSB, Quarterly Reports on Form 10-QSB and any Current Reports on Form 8-K filed by the Company. SOURCE CRYO-CELL International, Inc. -0- 05/24/2004 /CONTACT: Todd Atenhan of CRYO-CELL International, +1-727-450-8000, or fax, +1-727-723-0444, or investor.relations@cryo-cell.com / /Web site: http://www.cryo-cell.comhttp://www.cryo-cell.com.mx / (CCEL) CO: CRYO-CELL International, Inc.; CRYO-CELL de Mexico; Alfred I. duPont Hospital for Children ST: Florida, Mexico, El Salvador, Delaware IN: MTC OTC BIO HEA SU:
------------------ Due Da Due......But Be Quick About It!!!!!
posted
CCEL - CRYO-CELL INTL (OTCBB) Date Open High Low Last Change Volume % Change 06/21/04 1.37 1.41 1.34 1.40 +0.04 62223 +2.94%
Composite Indicator Trend Spotter (TM) Buy
Short Term Indicators 7 Day Average Directional Indicator Buy 10 - 8 Day Moving Average Hilo Channel Buy 20 Day Moving Average vs Price Buy 20 - 50 Day MACD Oscillator Buy 20 Day Bollinger Bands Hold
Short Term Indicators Average: 80% - Buy 20-Day Average Volume - 91361
Medium Term Indicators 40 Day Commodity Channel Index Buy 50 Day Moving Average vs Price Buy 20 - 100 Day MACD Oscillator Buy 50 Day Parabolic Time/Price Buy
Medium Term Indicators Average: 100% - Buy 50-Day Average Volume - 50296
Long Term Indicators 60 Day Commodity Channel Index Buy 100 Day Moving Average vs Price Buy 50 - 100 Day MACD Oscillator Buy
Long Term Indicators Average: 100% - Buy 100-Day Average Volume - 36530
Overall Average: 96% - Buy
Price Support Pivot Point Resistance
1.40 1.31 1.38 1.45
------------------ Due Da Due......But Be Quick About It!!!!!
HQNT got killed today - still, bought 2000 more shares since the fundamentals look great! Think it's a real buy now. When they release their earnings report (on or before 6/24) I think it will give a loud bark. LOL
Hope I did not offend you by referring to your post on the CMKX thread. Maybe I did misunderstand your reference to receipt of the certificates. If so, sorry.
PS If you give me some way to contact you by email, I do not mind telling you what my WS experience has been.
[This message has been edited by Wallace#1 (edited June 21, 2004).]
posted
CCEL - CRYO-CELL INTL (OTCBB) Date Open High Low Last Change Volume % Change 06/21/04 1.37 1.59 1.34 1.55 +0.19 243148 +13.97%
Composite Indicator Trend Spotter (TM) Buy
Short Term Indicators 7 Day Average Directional Indicator Buy 10 - 8 Day Moving Average Hilo Channel Buy 20 Day Moving Average vs Price Buy 20 - 50 Day MACD Oscillator Buy 20 Day Bollinger Bands Buy
Short Term Indicators Average: 100% - Buy 20-Day Average Volume - 100407
Medium Term Indicators 40 Day Commodity Channel Index Buy 50 Day Moving Average vs Price Buy 20 - 100 Day MACD Oscillator Buy 50 Day Parabolic Time/Price Buy
Medium Term Indicators Average: 100% - Buy 50-Day Average Volume - 53915
Long Term Indicators 60 Day Commodity Channel Index Buy 100 Day Moving Average vs Price Buy 50 - 100 Day MACD Oscillator Buy
Long Term Indicators Average: 100% - Buy 100-Day Average Volume - 38339
Ran across your old post re the split/spin off shs. No question, if the x date was the date you specified and you sold the shares after that date, your own the new shares. Whoever bought them after the x date bought them without (that's what x means) the dividend. This info is probably too late for you use but thought I would post it just in case. I very frequently worked with Co's re stock splits and stock dividends. I cannot imagine an OTCBB or OTCPK company treating x dates in any other manner. Won't be adding another post on this thread.
[This message has been edited by Wallace#1 (edited June 21, 2004).]
[This message has been edited by Wallace#1 (edited June 21, 2004).]
posted
CCEL - CRYO-CELL INTL (OTCBB) Date Open High Low Last Change Volume % Change 06/22/04 1.59 2.05 1.57 1.90 +0.35 353700 +22.58%
Composite Indicator Trend Spotter (TM) Buy
Short Term Indicators 7 Day Average Directional Indicator Buy 10 - 8 Day Moving Average Hilo Channel Buy 20 Day Moving Average vs Price Buy 20 - 50 Day MACD Oscillator Buy 20 Day Bollinger Bands Buy
Short Term Indicators Average: 100% - Buy 20-Day Average Volume - 117965
Medium Term Indicators 40 Day Commodity Channel Index Buy 50 Day Moving Average vs Price Buy 20 - 100 Day MACD Oscillator Buy 50 Day Parabolic Time/Price Buy
Medium Term Indicators Average: 100% - Buy 50-Day Average Volume - 60916
Long Term Indicators 60 Day Commodity Channel Index Buy 100 Day Moving Average vs Price Buy 50 - 100 Day MACD Oscillator Buy
Long Term Indicators Average: 100% - Buy 100-Day Average Volume - 41851
posted
Cryo Cell International Inc 3165 McMullen Booth Road, Building B Clearwater, FL 33761 Phone: (727) 450-8000 Fax: (727) 723-0444 Web Site: http://www.cryo-cell.com
DETAILS Index Membership: N/A Sector: Healthcare Industry: Medical Equipment & Supplies Employees (last reported count): 31
REUTERS ABRIDGED BUSINESS SUMMARY CRYO-CELL International, Inc. is engaged in cryogenic cellular storage, with a focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. The Company pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment. These technologies include the storage of fractionated (separated) U-Cord stem cells and the development and patenting of the first computer controlled, robotically operated cryogenic storage system Its headquarters facility in Clearwater, Florida handles all aspects of its business operations including the processing and storage of specimens. In October 2002, CRYO-CELL introduced a dual storage program whereby a portion of newly processed specimens are stored in its Clearwater, Florida facility and the balance of the collected specimen are stored at a facility in Arizona. The specimens are stored in commercially available cryogenic storage equipment.
For the three months ended 2/29/04, revenues rose 80% to $2.6 million. Net income totaled $310 thousand, vs. a loss of $754 thousand. Revenues reflect price increases, and higher recurring annual storage fees. Earnings also reflect improved operating margins and a $135 thousand income from litigation settlement.
posted
This will break through the resistance again today. To bad I appear to be only one making bank on it. But not so bad I won't ride all week solo. heh heh
Ruff.
------------------ Due Da Due......But Be Quick About It!!!!!
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
ruff
